Literature DB >> 6162016

A simplified radioimmunological method for the determination of human beta-endorphin in cerebrospinal fluid.

H Przuntek, J P Stasch, M Graf, K W Pflughaupt, N Gropp, M Witteler.   

Abstract

Human beta-endorphin-like immunoreactive substances (beta h-EI) in human cerebrospinal fluid (CSF) were determined radioimmunologically. The cross reactivity of the antibodies to human beta-endorphin (beta h-E) amounted to 40% for human beta-lipotropin (beta h-LPH) whilst it was less than 1% for leu- and metenkephalin, alpha- and gamma-endorphin, fraction I and II [5], substance P and alpha-MSH. Prior to radioimmunological determination, an adsorbtion of beta h-EI from CSF with silicic acid was carried out and followed by a desorbtion, using a mixture of aceton/hydrochloric acid. This method was chosen because of the ratio of beta h-LPH to beta h-E in the desorbate can be shifted in favour of beta h-E owing to the variation in recoveries r (r beta h-LPH = 33%, r beta h-E = 64%). On the one hand, this enables a more specific determination of beta h-E and, on the other hand, and separation of any peptidase than may be present [9]. An adsorbtion/desorbtion of 2 ml CSF surfaces to prove the presence of 20-150 pg/ml (65-48 fmol/ml) of beta h-EI. The CSF of 28 patients with various neurological diseases was examined and 24 of them had concentrations of 20-70 pg/ml beta h-EI. The remaining four which had concentrations less than 20 pg/ml, came from meningitis patients undergoing corticoid therapy. A purchasable RIA kid was tested for its determination of beta h-E and was found to be unsuitable.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162016     DOI: 10.1007/BF00313282

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  beta-Endorphin in human plasma: basal and pathologically elevated levels.

Authors:  V Höllt; O A Müller; R Fahlbusch
Journal:  Life Sci       Date:  1979-07-02       Impact factor: 5.037

Review 2.  [Endorphin--endogenous peptides with morphine-like effects. 1. Methods for detection, structural characteristics, incidence, effects].

Authors:  W Kromer
Journal:  Fortschr Med       Date:  1978-07-27

3.  Radioimmunoassays for alpha-endorphin and beta-endorphin.

Authors:  R Guillemin; N Ling; T Vargo
Journal:  Biochem Biophys Res Commun       Date:  1977-07-11       Impact factor: 3.575

4.  Radioimmunoassay of brain peptides: evaluation of a methodology for the assay of beta-endorphin and enkephalin.

Authors:  J Rossier; A Bayon; T M Vargo; N Ling; R Guillemin; F Bloom
Journal:  Life Sci       Date:  1977-09-15       Impact factor: 5.037

5.  Beta-Endorphin: lack of correlation between opiate activity and immunoreactivity by radioimmunoassay.

Authors:  C H Li; A J Rao; B A Donnen; D Yamashiro
Journal:  Biochem Biophys Res Commun       Date:  1977-04-11       Impact factor: 3.575

Review 6.  [Endorphins--endogenous peptides with morphine-like effects. 2. Biological importance, clinical apsects].

Authors:  W Kromer
Journal:  Fortschr Med       Date:  1978-08-03

7.  beta-Endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders.

Authors:  H M Emrich; V Höllt; W Kissling; M Fischler; H Laspe; H Heinemann; D von Zerssen; A Herz
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1979-05

8.  Common precursor to corticotropins and endorphins.

Authors:  R E Mains; B A Eipper; N Ling
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Radioimmunoassay of beta-endorphin basal and stimulated levels in extracted rat plasma.

Authors:  V Höllt; R Przewlocki; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

10.  beta-Endorphin in human cerebrospinal fluid.

Authors:  W J Jeffcoate; L H Rees; L McLoughlin; S J Ratter; J Hope; P J Lowry; G M Besser
Journal:  Lancet       Date:  1978-07-15       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.